The Definitive Peptide Research Reference Guide — Compound Review

Home Compounds BPC-157 TB-500 CJC-1295 Ipamorelin GLP-1 GHK-Cu Epithalon NAD+ Comparisons BPC-157 vs TB-500 Sermorelin vs Ipamorelin Semaglutide vs Tirzepatide Guides GHK-Cu Guide GHRH Analogues Ipamorelin Guide Peptide Reconstitution Guide Peptide Injection Sites Guide Peptide Storage Guide Semaglutide Dosage BPC-157 Dosage Research Guides Joint Pain Weight Loss Longevity Vendor Scoreboard All Vendor Comparisons Peptide Price Comparison Vendor Closures & Status How to Read a Peptide COA How to Vet a Peptide Vendor Why Purgo Labs Purgo Labs Review Purgo Labs Discount Code Where to Buy by Compound Legal Status Shop Purgo Labs

Sermorelin Research Hub

The definitive reference for sermorelin research — covering GHRH mechanism, dosage protocols, head-to-head comparisons with HGH and ipamorelin, side effects, legal status, and sourcing.

Mechanism & Research

Full mechanism overview: GHRH receptor agonism, pulsatile GH release, IGF-1 upregulation, and clinical applications. Sermorelin preserves the hypothalamic-pituitary feedback axis — unlike exogenous HGH.

Dosage & Protocols

Standard dosing protocol: 200–500 mcg subcutaneous injection before sleep, leveraging the natural nocturnal GH pulse. Cycle length typically 3–6 months for research applications.

Side Effects & Safety

Injection site reactions, flushing, water retention, and rare adverse events. Evidence-graded safety profile with comparison to exogenous HGH — sermorelin's axis-preserving mechanism produces a more favorable safety profile.